Search
for
Sort by
Research 721–750 of 1000+
- E.L.F. sqare waves: a new therapy for androgenetic alopecia?
- The PDGF/PDGFR pathway as a drug target
- The pharmacology of methotrexate
- Lupus erythematosus: systemic and cutaneous manifestations
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- Regulatory T Cells: the Many Faces of Foxp3
- Tinea Capitis: An Overview with Emphasis on Management
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis
- Adverse Cutaneous Reactions to Antidepressants
- Tissue resident and follicular Treg cell differentiation is regulated by CRAC channels
- Side effects of common acne treatments
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- <i>Hedychium spicatum</i>: a systematic review on traditional uses, phytochemistry, pharmacology and future prospectus
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Chaos and antichaos in pathology
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- ADVANCES IN PSORIASIS THERAPY
- Topical absorption and systemic toxicity
- Anticonvulsant-Induced Cutaneous Reactions
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Non-hemorrhage-related adverse effects of rivaroxaban
- Primary cutaneous follicle centre cell lymphoma of the scalp presenting with scarring alopecia
- Psychoactive drugs and skin
- Clinical Development of Topoisomerase-Interactive Drugs
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- Autoimmune gastritis and parietal cell reactivity in two children with abnormal intestinal permeability